Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective

OBJECTIVES: To evaluate the cost effectiveness of onabotulinumtoxinA (BOTOX(®), 200 units [200 U]) for the management of urinary incontinence (UI) in adults with neurogenic detrusor overactivity (NDO) due to subcervical spinal cord injury or multiple sclerosis that is not adequately managed with ant...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmacoeconomics
Egile Nagusiak: Hamid, Rizwan, Loveman, Clara, Millen, Jim, Globe, Denise, Corbell, Catherine, Colayco, Danielle, Stanisic, Sanja, Gultyaev, Dmitry
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2014
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4381108/
https://ncbi.nlm.nih.gov/pubmed/25526842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-014-0245-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak